Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

China flag China · Delayed Price · Currency is CNY
28.84
+0.20 (0.70%)
Apr 30, 2026, 11:05 AM CST
-4.09%
Market Cap 6.71B
Revenue (ttm) 2.02B
Net Income (ttm) 463.31M
Shares Out 234.33M
EPS (ttm) 1.97
PE Ratio 14.53
Forward PE 11.19
Dividend 2.50 (8.83%)
Ex-Dividend Date n/a
Volume 1,479,250
Average Volume 3,815,727
Open 29.20
Previous Close 28.64
Day's Range 28.54 - 29.20
52-Week Range 28.01 - 36.70
Beta 0.11
RSI 31.68
Earnings Date Apr 24, 2026

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and succinate capsules. In addition, it offers information product... [Read more]

Sector Healthcare
Founded 1993
Employees 1,759
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000915
Full Company Profile

Financial Performance

In 2025, Shandong Wit Dyne Health's revenue was 2.23 billion, an increase of 4.40% compared to the previous year's 2.13 billion. Earnings were 535.08 million, an increase of 3.78%.

Financial Statements

News

There is no news available yet.